Thomas Joseph (TJ) O’Neill, MD, is an advanced heart failure and heart transplantation specialist with University Hospitals Harrington Heart & Vascular Institute.
Dr. O’Neill is board certified in internal medicine, cardiovascular disease, and advanced heart failure and transplant cardiology. He earned his medical degree from the University of Virginia School of Medicine and completed an internal medicine residency and cardiovascular disease fellowship at the University of North Carolina, Chapel Hill. He completed a second fellowship in advanced heart failure and cardiac transplantation at the University of Pennsylvania in Philadelphia. Dr. O’Neill has earned several clinical and academic honors during his tenure.
Beyond his clinical practice, Dr. O’Neill is an avid researcher, with roles as principal investigator or co-principal investigator on multiple heart failure related clinical trials. Additionally, he has provided over 40 professional lectures on the management of advanced heart failure and authored numerous peer-reviewed publications and abstracts.
Dr. O’Neill is an active member of renowned organizations including the American College of Cardiology, American Society of Transplantation, Heart Failure Society of American, and the International Society of Heart and Lung Transplantation.
Certifications & Memberships
- Advanced Heart Failure and Transplant Cardiology - American Board of Internal Medicine
- Cardiovascular Disease - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Fellowship | Heart Failure and Cardiac Transplantation
Heart Failure and Cardiac Transplantation - Pennsylvania Hospital (UPHS) (2014 - 2015)
Fellowship | Cardiovascular Disease
Cardiovascular Disease - University Of North Carolina Health Care (2012 - 2014)
Fellowship | Cardiology
Cardiology - University Of North Carolina Health Care (2010 - 2012)
Residency | Internal Medicine
Internal Medicine - University Of North Carolina Health Care (2007 - 2010)
University Of Virginia School Of Medicine (2007)
University Of Virginia (2006)
Dartmouth College (1999)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Thomas O'Neill did not disclose any Outside Relationships with Industry.